+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oxford Nanopore Technologies Plc (ONT) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 57 Pages
  • June 2023
  • GlobalData
  • ID: 5703380
Oxford Nanopore Technologies Plc (ONT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - Analyst's summarization of the company's business strategy.
  • SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Oxford Nanopore Technologies Plc (Oxford Nanopore), formerly Oxford NanoLabs Ltd develops disruptive, electronic, and single-molecule sensing system. The company's products include SmidgION, Flongle, MinION, PromethION and GridION used for the analysis of DNA, RNA, proteins, small molecules and other types of molecule. Its products find applications in various areas of research such as microbiology, environmental research, microbiome, basic genome research, human genetics, cancer research, clinical research, plant research, transcriptome analysis, population genomics and animal research. The company also offers support, certification and training services. It works in partnership with various academic and industry research groups to launch new genomic and medical applications through its nanopore technology. Oxford Nanopore is headquartered in Oxford, the UK.

Oxford Nanopore Technologies Plc Key Recent Developments

  • Jun 09, 2023: Oxford Nanopore Technologies and Geneyx Announce the First Scalable Software Solution to Advance the Future Clinical Use of Nanopore Sequencing
  • Apr 14, 2023: Oxford Nanopore and BioMerieux to enter into a strategic partnership agreement to develop innovative infectious disease diagnostics
  • Mar 31, 2023: Announces new human health and disease study led by the UK National Institute for Health and Care Research (NIHR) BioResource
  • Mar 21, 2023: Oxford Nanopore Technologies Announces Final results for the year ended 31 December 2022

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Oxford Nanopore Technologies Plc - Key Facts
  • Oxford Nanopore Technologies Plc - Key Employees
  • Oxford Nanopore Technologies Plc - Key Employee Biographies
  • Oxford Nanopore Technologies Plc - Major Products and Services
  • Oxford Nanopore Technologies Plc - History
  • Oxford Nanopore Technologies Plc - Company Statement
  • Oxford Nanopore Technologies Plc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Oxford Nanopore Technologies Plc - Business Description
  • Business Segment: Covid-19 Testing
  • Overview
  • Performance
  • Business Segment: Life Science Research Tools (LSRT)
  • Overview
  • Performance
  • Geographical Segment: Americas
  • Performance
  • Geographical Segment: Asia Pacific and Japan
  • Performance
  • Geographical Segment: China
  • Performance
  • Geographical Segment: Emerging Markets
  • Performance
  • Geographical Segment: Europe and United Kingdom
  • Performance
  • Geographical Segment: United Arab Emirates
  • Performance
  • R&D Overview
  • Oxford Nanopore Technologies Plc - Corporate Strategy
  • Oxford Nanopore Technologies Plc - SWOT Analysis
  • SWOT Analysis - Overview
  • Oxford Nanopore Technologies Plc - Strengths
  • Oxford Nanopore Technologies Plc - Weaknesses
  • Oxford Nanopore Technologies Plc - Opportunities
  • Oxford Nanopore Technologies Plc - Threats
  • Oxford Nanopore Technologies Plc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Oxford Nanopore Technologies Plc, Medical Equipment, Deals By Year, 2017 to YTD 2023
  • Oxford Nanopore Technologies Plc, Medical Equipment, Deals By Type, 2017 to YTD 2023
  • Oxford Nanopore Technologies Plc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jun 09, 2023: Oxford Nanopore Technologies and Geneyx Announce the First Scalable Software Solution to Advance the Future Clinical Use of Nanopore Sequencing
  • Apr 14, 2023: Oxford Nanopore and BioMerieux to enter into a strategic partnership agreement to develop innovative infectious disease diagnostics
  • Mar 31, 2023: Announces new human health and disease study led by the UK National Institute for Health and Care Research (NIHR) BioResource
  • Mar 21, 2023: Oxford Nanopore Technologies Announces Final results for the year ended 31 December 2022
  • Mar 21, 2023: Oxford Nanopore and PathoQuest announce the first steps in a strategic collaboration to bring the first GMP-accredited, nanopore-based biologics genetic characterisation test to market
  • Mar 20, 2023: Oxford Nanopore and 4bases announce collaboration to combine nanopore sequencing devices and 4bases kits to support rapid, high-accuracy analyses in human and cancer genetics, with a first target of same-day BRCA1 and BRCA2 analysis
  • Mar 16, 2023: Oxford Nanopore Technologies and Cyclomics begin developer testing on non-invasive method for accurate and fast detection of molecules associated with cancer
  • Feb 27, 2023: Oxford Nanopore Technologies : Changes to Director roles and responsibilities
  • Feb 09, 2023: SeqOne genomics and the French Thrombotic MicroAngiopathies National Reference Center (CNR-MAT) pioneer the use of oxford nanopore sequencing technology to improve patient outcomes in kidney disease while reducing turnaround times
  • Jan 17, 2023: Oxford Nanopore Technologies : Trading update
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Oxford Nanopore Technologies Plc, Key Facts
  • Oxford Nanopore Technologies Plc, Key Employees
  • Oxford Nanopore Technologies Plc, Key Employee Biographies
  • Oxford Nanopore Technologies Plc, Major Products and Services
  • Oxford Nanopore Technologies Plc, History
  • Oxford Nanopore Technologies Plc, Other Locations
  • Oxford Nanopore Technologies Plc, Key Competitors
  • Oxford Nanopore Technologies Plc, Ratios based on current share price
  • Oxford Nanopore Technologies Plc, Annual Ratios
  • Oxford Nanopore Technologies Plc, Interim Ratios
  • Oxford Nanopore Technologies Plc, Medical Equipment, Deals By Year, 2017 to YTD 2023
  • Oxford Nanopore Technologies Plc, Medical Equipment, Deals By Type, 2017 to YTD 2023
  • Oxford Nanopore Technologies Plc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Oxford Nanopore Technologies Plc, Performance Chart (2018 - 2022)
  • Oxford Nanopore Technologies Plc, Ratio Charts
  • Oxford Nanopore Technologies Plc, Medical Equipment, Deals By Year, 2017 to YTD 2023
  • Oxford Nanopore Technologies Plc, Medical Equipment, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Illumina Inc
  • Source BioScience (Healthcare) Ltd
  • Pacific Biosciences of California Inc
  • Roche Diagnostics International Ltd
  • NanoString Technologies Inc
  • Quest Diagnostics Inc
  • Exact Sciences Corp
  • Adaptive Biotechnologies Corp